Innovative Radiopharmaceuticals in Oncology and Neurology

The aim of this Research Topic was to assemble a series of articles describing basic, preclinical and clinical research studies on radiopharmaceuticals and nuclear medicine. The articles were written by attendees of the third Nuclear Technologies for Health Symposium (NTHS, 10th-11th March 2015, Nan...

Full description

Saved in:
Bibliographic Details
Main Author: Michel Cherel (auth)
Other Authors: Jacques Barbet (auth), Francoise Kraeber-Bodere (auth), Denis Guilloteau (auth)
Format: Book Chapter
Published: Frontiers Media SA 2017
Subjects:
Online Access:Get Fullteks
DOAB: description of the publication
Tags: Add Tag
No Tags, Be the first to tag this record!
LEADER 02333naaaa2200349uu 4500
001 doab_20_500_12854_50301
005 20210211
020 |a 978-2-88945-174-6 
020 |a 9782889451746 
024 7 |a 10.3389/978-2-88945-174-6  |c doi 
041 0 |a English 
042 |a dc 
100 1 |a Michel Cherel  |4 auth 
700 1 |a Jacques Barbet  |4 auth 
700 1 |a Francoise Kraeber-Bodere  |4 auth 
700 1 |a Denis Guilloteau  |4 auth 
245 1 0 |a Innovative Radiopharmaceuticals in Oncology and Neurology 
260 |b Frontiers Media SA  |c 2017 
300 |a 1 electronic resource (114 p.) 
506 0 |a Open Access  |2 star  |f Unrestricted online access 
520 |a The aim of this Research Topic was to assemble a series of articles describing basic, preclinical and clinical research studies on radiopharmaceuticals and nuclear medicine. The articles were written by attendees of the third Nuclear Technologies for Health Symposium (NTHS, 10th-11th March 2015, Nantes, Frances) under the auspices of the IRON LabEx (Innovative Radiopharmaceuticals for Oncology and Neurology Laboratory of Excellence). This French network, gathering approximately 160 scientists from 12 academic research teams (Funded by "investissements d'Avenir"), fosters transdisciplinary projects between teams with expertise in chemistry, radiochemistry, radiopharmacy, formulation, biology, nuclear medicine and medical physics. The 12 articles within this resulting eBook present a series of comprehensive reviews and original research papers on multimodality imaging and targeted radionuclide therapy; illustrating the different facets of studies currently conducted in these domains. 
540 |a Creative Commons  |f https://creativecommons.org/licenses/by/4.0/  |2 cc  |4 https://creativecommons.org/licenses/by/4.0/ 
546 |a English 
653 |a multimodality imaging 
653 |a PET imaging 
653 |a targeted radionuclide therapy 
653 |a Radiopharmaceuticals 
653 |a theranostic 
653 |a Pretargeted radioimmunotherapy 
653 |a personalized medicine 
856 4 0 |a www.oapen.org  |u http://journal.frontiersin.org/researchtopic/3871/innovative-radiopharmaceuticals-in-oncology-and-neurology  |7 0  |z Get Fullteks 
856 4 0 |a www.oapen.org  |u https://directory.doabooks.org/handle/20.500.12854/50301  |7 0  |z DOAB: description of the publication